CHIARUCCI, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 458
EU - Europa 206
AS - Asia 30
Totale 694
Nazione #
US - Stati Uniti d'America 458
IT - Italia 57
UA - Ucraina 37
SE - Svezia 33
IE - Irlanda 24
DE - Germania 16
DK - Danimarca 14
TR - Turchia 10
CN - Cina 7
FI - Finlandia 6
FR - Francia 6
GB - Regno Unito 6
SG - Singapore 6
KR - Corea 5
PL - Polonia 4
BE - Belgio 3
IN - India 1
JP - Giappone 1
Totale 694
Città #
Chandler 78
Ashburn 37
Jacksonville 37
Fairfield 32
Des Moines 28
New York 28
Centro 27
Dublin 24
Wilmington 23
Woodbridge 22
Seattle 17
Redmond 16
Houston 15
Cambridge 14
Boardman 10
Lawrence 10
Princeton 10
San Diego 9
San Mateo 9
Ann Arbor 6
Beijing 6
Turin 6
Milan 5
Brussels 3
Marche 3
Washington 3
Campobasso 1
Chengdu 1
Helsinki 1
Kagoya 1
Norwalk 1
Pescara 1
Porto 1
Portsmouth 1
Prescot 1
Pune 1
Rome 1
Totale 489
Nome #
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 92
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 85
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 84
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 80
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 76
Application of infrared thermography to determine the correlation between skin temperature and onset of graft versus host disease in patients after bone marrow transplantation: A preliminary study 76
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 69
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 65
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 59
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study 27
Totale 713
Categoria #
all - tutte 3.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202048 2 0 5 0 9 0 10 2 7 1 5 7
2020/2021176 9 14 10 30 21 16 7 16 11 18 14 10
2021/2022101 5 13 2 2 0 6 7 14 2 8 22 20
2022/2023222 16 27 11 15 19 50 0 13 51 0 16 4
2023/202483 13 4 3 9 16 37 0 1 0 0 0 0
Totale 713